SEC Form 4 · accession 0001493152-18-017755
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandra M Gurrola
Officer — VP of Finance
Period of report
Dec 19, 2018
Accepted (ET)
Dec 20, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 19, 2018 | F | 28 | $2.00 | D | 3,050 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2018. No shares were sold in connection with this transaction.